Updates matching "Access to Biomarker Testing"

Earlier today, cancer survivors, medical professionals and patient advocates from across Delaware convened in Dover at Legislative Hall as a part of ‘Delaware Advocacy Day.’ The main focus of Advocacy Day, which was hosted by the American Cancer Society Cancer Action Network (ACS CAN) and the Alzheimer’s Association (ALZ), was for volunteers to connect directly with legislators and ask for their support of Senate Bill 120, a bipartisan proposal to improve Delawareans’ access to biomarker testing.

The one-house budget proposals revealed a clear divide in the Legislature’s approach to the equitable treatment of disease. The New York State Senate flatly rejected the governor’s proposal to roll back Medicaid coverage criteria for biomarker testing, heeding the calls of cancer survivors, patient advocates and public health organizations, like the American Cancer Society Cancer Action Network (ACS CAN). The Assembly took a more mixed approach accepting parts of the Governor’s proposed language while rejecting others.

JACKSON, Miss. – The Mississippi Senate passed “Jill’s Law” House Bill 565 Wednesday, paving the way for increased access to biomarker testing for Mississippians with state-regulated health insurance plans. Biomarker testing is a key tool used by physicians to identify the most effective treatments for cancer and

JACKSON, Miss. – The Mississippi Senate passed Senate Bill 2694 Wednesday, February 11, paving the way for increased access to biomarker testing for patients across the Magnolia State. Biomarker testing is a key tool used by physicians to identify the most effective treatments for cancer and other

Following today’s health-Medicaid budget hearing, more than a dozen cancer survivors and ACS CAN advocates gathered at the New York State Capitol to call on lawmakers to preserve access to biomarker testing, a priority shared by over 100 organizations statewide . Advocates also expressed hope that the one‑house and final budgets will include meaningful investments in cancer prevention and early detection.

NASHVILLE, Tenn. – Advocates from the American Cancer Society Cancer Action Network (ACS CAN), the Alzheimer’s Association and the Arthritis Foundation will join together on Tuesday, February 3, to host a news conference calling on lawmakers to pass legislation that would ensure appropriate coverage of biomarker testing. The news conference

JACKSON, Miss. – Dozens of cancer patients, survivors, caregivers and advocates will come from across Mississippi to the State Capitol on Wednesday, February 4 for the American Cancer Society Cancer Action Network’s (ACS CAN) annual Cancer Action Day . They will urge state lawmakers to make cancer policy

JACKSON, Miss. – The Mississippi House passed House Bill 565 Wednesday, paving the way for increased access to biomarker testing for patients across the Magnolia State. Biomarker testing is a key tool used by physicians to identify the most effective treatments for cancer and other diseases. “In

With the 2026 legislative session now underway in Hawai’i, the American Cancer Society Cancer Action Network (ACS CAN) is leading efforts to work with lawmakers on several initiatives which include defending Medicaid and expanding access to screenings for colorectal cancer for the state’s most vulnerable communities. ACS CAN is collaborating